1. 1. TN Lee, WE Alborn, MD Knierman, and RJ Konrad . The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity . 2006 ; 72 : 710 -18 .
2. 2. R Candido, KA Jandeleit-Dahm, and Z Cao et al.Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice . 2002 ; 106 : 246 -53 .
3. 3. SB Gurley, SE Clare, KP Snow, A Hu, TW Meyer, and TM Coffman . Impact of genetic background on nephropathy in diabetic mice . 2006 ; 290 : F214 -22 .
4. 4. YC Tay, Y Wang, L Kairaitis, GK Rangan, C Zhang, and D Harris . Can murine diabetic nephropathy be separated from superimposed acute renal failure? 2005 ; 68 : 391 -8 .
5. 5. AR Kraynak, RD Storer, and RD Jensen et al.Extent and persistence of streptozotocin-induced DNA damage and cell proliferation in rat kidney as determined by in vivo alkaline elution and BrdUrd labeling assays . 1995 ; 135 : 279 -86 .